Led · Series A · Jul 2026

Keiron develops the HF2 LiFT Printer, a digital, non-contact platform that replaces traditional stencil printing, jet printing and SPI inspection in electronics assembly. The company reports first-pass yield improvements from an industry-typical ~60% to above 95%, a twofold reduction in production lead time, doubled production uptime, and programming that is ten times faster. Those performance gains target high-mix, low-to-medium-volume electronics production, with benefits cited for throughput, working capital and EBITDA. Keiron is a TNO spin-off and has attracted a mix of public and private investors in its recent Series A. The company plans to use the Series A proceeds to scale production and expand its market presence.

Participated · Seed · Jun 2026

Recess operates a marketplace designed to simplify discovery and booking of children’s enrichment activities and camps. The company was founded in 2024 by Amy Kiska (CEO) and Molly Morse (COO) and is based in Austin, Texas. Recess launched to address fragmentation in summer camp and activities booking, consolidating options that parents previously managed across multiple sites and spreadsheets. It is currently live in Austin, Dallas, and Houston and plans to expand nationwide. The company announced it raised more than $4 million in Seed venture funding from investors including Baukunst, Wave Capital, Swizzle Ventures, and Laura Modi to support that expansion.

Participated · Seed · Dec 2025

Daisy Genomics is an Albuquerque-based startup building technology for precision medicine. The company’s platform focuses on leveraging genomic information to tailor medical treatments to individual patients. Though still early stage, Daisy Genomics has attracted investor attention for its potential to advance personalized healthcare. The firm recently secured seed financing to accelerate product development and expand its scientific and engineering team. No operating metrics such as revenue, user count, or customer numbers have been disclosed. The new capital will support continued R&D and go-to-market preparations as the company refines its precision medicine offerings.

Participated · Series A · Dec 2025

Delft Circuits focuses on Cri/oFlex®, a flexible, cryogenic high-density I/O system engineered to remove the performance and thermal bottlenecks that traditional cabling introduces in large-scale qubit machines. The technology is sold to quantum hardware builders and is now being integrated into dilution refrigerators through a partnership with Bluefors. The firm recently hired long-time Boston Consulting Group veteran Martin Danoesastro as CEO to steer its next growth phase. Fresh capital will fund continued product innovation, additional technical hires, and expanded manufacturing capacity. Management also intends to leverage new investor Paeonia Group’s network to enter North American and Asian markets. A next-generation Cri/oFlex® product roadmap has already been published, underscoring plans to stay ahead of emerging quantum-computing I/O requirements. Including the latest extension, Delft Circuits has raised €15 million ($17.5 million) to date.

Participated · Seed · Dec 2025

Founded in 2022 and based in Amsterdam, Orq.ai offers a unified control layer that covers the entire AI agent lifecycle—from experimentation and evaluation to observability, governance, and runtime. The platform is designed to close the "production gap" that often prevents enterprise AI prototypes from operating reliably at scale, giving engineering teams clarity on model behaviour, data flows, and regulatory compliance. Its architecture lets customers run AI workloads on their own infrastructure, satisfy data-residency requirements, and reduce dependence on external providers—features that resonate with highly regulated industries and the public sector. Unlike point solutions focused on a single step, Orq.ai bundles experimentation, AI gateway, monitoring, and governance in a single environment, simplifying industrial-grade deployments. With regulatory pressures such as GDPR and the forthcoming EU AI Act intensifying, the company positions itself as essential infrastructure for compliant AI operations. To date, Orq.ai has raised a total of €7.3 million. The newly secured capital will be used to grow its engineering, enterprise sales, and customer-success teams, deepen its European footprint, and kick-start expansion in North America.